ResearchPod Summary
People living with HIV (PLWH) often experience neurocognitive impairments, even when their viral load is suppressed by antiretroviral therapy (cART). The researchers investigated whether the accumulation and aggregation of alpha-synuclein (α-Syn)—a process associated with Parkinson-like symptoms—is driven by HIV-1 viral proteins, specifically through epigenetic modification of the gene responsible for α-Syn production (SNCA).
This study used a multi-model approach to characterize the link between HIV-1 Vpr and α-Syn regulation. The authors examined brain tissues from HIV-positive patients (with and without cART) to evaluate methylation levels at the SNCA antisense promoter. They utilized SH-SY5Y neuroblastoma cells and primary mouse neurons to observe the direct effects of recombinant Vpr treatment on α-Syn mRNA, protein expression, and promoter demethylation. Additionally, they treated cells with DMOG, a Tet-enzyme inhibitor, to verify the role of DNA demethylation. Finally, they performed behavioral (object location memory) and electrophysiological (long-term potentiation) assays on mice injected with Vpr to test the functional consequences of these molecular changes.
Vpr protein was found to significantly increase α-Syn expression by inducing the demethylation of the SNCA antisense promoter, particularly at specific CpG sites within intron 1. This epigenetic shift leads to a pathological buildup of α-Syn, which the authors show contributes to synaptic dysfunction and impaired spatial memory in mice. The study further demonstrates that these changes occur in human brain tissues regardless of cART use, suggesting a persistent epigenetic modification caused by the virus. Treatment with DMOG successfully reversed this process, preventing the Vpr-induced activation of the antisense promoter and the subsequent overexpression of α-Syn.
These results offer a compelling mechanistic link between HIV-1 infection and neurodegeneration. By identifying the SNCA antisense promoter as a target for viral protein-induced epigenetic reprogramming, this study clarifies why HAND-associated motor and cognitive decline persist despite antiretroviral treatment. Furthermore, the findings highlight potential novel therapeutic targets, such as epigenetic modulators, to mitigate the long-term neurocognitive effects of chronic HIV infection.
AI-generated third-party summary by ResearchPod. Not official content or an endorsement by the paper authors or affiliated organizations.